Investigation of anti-atherogenic effects of the alpha-tocopherol long-chain metabolites alpha-13-OH and alpha-13-COOH
α-生育酚长链代谢物 α-13-OH 和 α-13-COOH 的抗动脉粥样硬化作用的研究
基本信息
- 批准号:299250208
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:Research Fellowships
- 财政年份:2016
- 资助国家:德国
- 起止时间:2015-12-31 至 2017-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Atherosclerosis and its complications such as stroke and myocardial infarction are a leading cause of death in Western industrialized societies. Hence, research on underlying mechanisms and therapeutic approaches are on greater demand than ever. Based on several results obtained from in vitro and animal studies, vitamin E and in particular its most active form a-tocopherol, was considered as a therapeutic agent for preventing atherosclerosis. However, the promising reports on vitamin E failed to be reproduced in humans.In hepatic a-tocopherol metabolism the long-chain metabolites a-13-OH and a-13-COOH are formed by cytochrome P (CYP)4F2/3A4-dependent omega-hydroxylation followed by omega-oxidation. Our preliminary data promote the hypothesis that the long-chain metabolites of a-tocopherol occur in human serum and are at least bioactive molecules mediating effects more effectively than a-tocopherol. Therefore, anti-atherogenic effects of a-13-OH and a-13-COOH should be investigated in comparison to a-tocopherol in vitro and in vivo.The aim of the project is to unravel the molecular modes of action of the long-chain metabolites of a-tocopherol, namely a-13-OH and a-13-COOH, and their effects on (i) platelet function, (ii) atherosclerosis in the Apoe knockout mouse model, and (iii) atherosclerotic plaque stability in a modified Apoe knockout mouse model. This mouse model is unique in its comparability to human unstable plaques in such characteristics as intraplaque hemorrhage, thin or disrupted fibrous caps, intraluminal thrombosis and neovascularization. In order to comprehensively study the effects of the long-chain metabolites on atherosclerosis, platelet function and plaque stability innovative molecular imaging technologies, molecular biological methods, histological stainings and lipidomic analysis will be used.The investigation of the effects of a-long-chain metabolites on atherosclerosis, plaque stability and platelet function will help to assess the real contribution and the molecular modes of action of vitamin E in cardiovascular complications. The project will provide important information whether the anti-atherogenic properties of a-long-chain metabolites found in vitro can be confirmed in vivo. This will contribute to the complete characterization of the biological effects of a-long-chain metabolites as regulatory molecules and their importance for the pathogenesis of atherosclerosis.
动脉粥样硬化及其并发症如中风和心肌梗塞是西方工业化社会的主要死亡原因。因此,对潜在机制和治疗方法的研究比以往任何时候都更有需求。基于从体外和动物研究获得的若干结果,维生素E,特别是其最活性形式α-生育酚,被认为是预防动脉粥样硬化的治疗剂。在肝脏α-生育酚代谢中,长链代谢产物α-13-OH和α-13-COOH是通过细胞色素P(α)4F 2/3A 4依赖的ω-羟基化,然后ω-氧化形成的。我们的初步数据促进了这样的假设,即α-生育酚的长链代谢物存在于人血清中,并且至少是比α-生育酚更有效地介导效应的生物活性分子。因此,α-13-OH和α-13-COOH的抗动脉粥样硬化作用应在体外和体内与α-生育酚进行比较研究。该项目的目的是揭示α-生育酚的长链代谢物,即α-13-OH和α-13-COOH的分子作用模式,以及它们对(i)血小板功能,(ii)Apoe敲除小鼠模型中动脉粥样硬化,和(iii)在改良的Apoe敲除小鼠模型中的动脉粥样硬化斑块稳定性。这种小鼠模型在斑块内出血、薄或破裂的纤维帽、腔内血栓形成和新血管形成等特征方面与人类不稳定斑块具有可比性。为了全面研究α-长链代谢物对动脉粥样硬化、血小板功能和斑块稳定性的影响,将采用创新的分子影像学技术、分子生物学方法、组织学染色和脂质组学分析等手段,研究α-长链代谢物对动脉粥样硬化的影响,斑块稳定性和血小板功能将有助于评估维生素E在心血管并发症中的真实的作用和分子作用模式。该项目将提供重要的信息,是否在体外发现的α-长链代谢产物的抗动脉粥样硬化特性可以在体内得到证实。这将有助于完整表征α-长链代谢物作为调节分子的生物学效应及其在动脉粥样硬化发病机制中的重要性。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Long-Chain Metabolites of Vitamin E: Metabolic Activation as a General Concept for Lipid-Soluble Vitamins?
- DOI:10.3390/antiox7010010
- 发表时间:2018-01-12
- 期刊:
- 影响因子:0
- 作者:Schubert M;Kluge S;Schmölz L;Wallert M;Galli F;Birringer M;Lorkowski S
- 通讯作者:Lorkowski S
P 048 – Garcinia kola – African ethno medication with anti-atherosclerotic effects?
P 048 â 藤黄果 â 具有抗动脉粥样硬化作用的非洲民族药物?
- DOI:10.1016/j.freeradbiomed.2017.04.133
- 发表时间:2017
- 期刊:
- 影响因子:7.4
- 作者:Wallert M;Heise J;Chen Y-C;Kluge S;Schmölz L;Schubert M;Searle AK;Koeberle A;Galli F;Werz O;Birringer O;Lorkowski S;Peter K
- 通讯作者:Peter K
Analytical strategies to assess the functional metabolome of vitamin E.
- DOI:10.1016/j.jpba.2016.01.056
- 发表时间:2016-05
- 期刊:
- 影响因子:3.4
- 作者:P. Torquato;Orsola Ripa;D. Giusepponi;R. Galarini;D. Bartolini;Maria Wallert;R. Pellegrino;G. Cruciani-G
- 通讯作者:P. Torquato;Orsola Ripa;D. Giusepponi;R. Galarini;D. Bartolini;Maria Wallert;R. Pellegrino;G. Cruciani-G
The vitamin E derivative garcinoic acid from Garcinia kola nut seeds attenuates the inflammatory response
- DOI:10.1016/j.redox.2019.101166
- 发表时间:2019-06-01
- 期刊:
- 影响因子:11.4
- 作者:Wallert, Maria;Bauer, Julia;Lorkowski, Stefan
- 通讯作者:Lorkowski, Stefan
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dr. Maria Wallert其他文献
Dr. Maria Wallert的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
基于spA-Gel负载Anti-HMGB1原位靶向免疫耐受的猪胰岛类器官移植研
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
TKIs氘代化修饰通过促进HCC铁死亡增强免疫原性并增敏anti-PD-1治疗的机制研究
- 批准号:JCZRQN202500319
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
肺癌外周血淋巴细胞亚群预测anti-PD1/PDL1疗效的鉴定及应用研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
构建α-突触核蛋白特异性CAR-Treg治疗抗NMDAR脑炎的研究
- 批准号:2025JJ80620
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
Anti-MDA5阳性皮肌炎病人的NK细胞数量与功能改变在间质性肺疾病中的作用与机制研究
- 批准号:MS25H100014
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
特发性膜性肾病血清标志物anti-PLA2R-IgG4检测方法的建立及临床应用
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
经 anti-GPC3 修饰的外泌体靶向递送索拉非尼与放疗联合诱
导肝细胞癌铁死亡的研究
- 批准号:2024JJ9608
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
CCL2介导PGK1的O-GlcNAc糖基化修饰诱导CAFs代谢重编程促进头颈癌anti-PD-1免疫治疗耐药的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
千金藤素通过自噬损伤导致的免疫原性细胞死亡促进 anti-PD1 治疗MSS 型结直肠癌的疗效与机制研究
- 批准号:
- 批准年份:2024
- 资助金额:10.0 万元
- 项目类别:省市级项目
周细胞 ZEB1/SPP1 旁分泌轴招募 MDSCs 诱导
卵巢癌 anti-PD1/PD-L1 疗法耐药的机制研究
- 批准号:Y24H310009
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
食品中の抗動脈硬化活性成分総合的研究
食品中抗动脉硬化活性成分的综合研究
- 批准号:
23K10811 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
- 批准号:
10603408 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Nutritional Metabolic Regulation of HDL Focusing on Functional Foods
HDL营养代谢调控聚焦功能食品
- 批准号:
20K11591 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms regulating the atherogenic activities of serum amyloid A
血清淀粉样蛋白 A 致动脉粥样硬化活性的调节机制
- 批准号:
10636872 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Mechanisms regulating the atherogenic activities of serum amyloid A
血清淀粉样蛋白 A 致动脉粥样硬化活性的调节机制
- 批准号:
10210327 - 财政年份:2020
- 资助金额:
-- - 项目类别:
The liver-x-receptor/endothelial progenitor cell secretome: a new source of anti-atherogenic proteins
肝脏-x-受体/内皮祖细胞分泌组:抗动脉粥样硬化蛋白的新来源
- 批准号:
406545 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Studentship Programs
Exercise induced anti-atherogenic effect: the mechanism of endothelial adaptations beyond active muscle
运动诱导的抗动脉粥样硬化作用:活跃肌肉之外的内皮适应机制
- 批准号:
17K01616 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




